Search clinical trials for: Rituximab Placebo
Total 56337 results
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in Pediatric...CompletedKidney Transplant | Kidney Transplant Recipient | Graft Function/Survival | de Novo HLA Antibodies DevelopmentUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; BiogenCompleted
-
Assistance Publique - Hôpitaux de ParisHoffmann-La RocheCompleted
-
Genentech, Inc.Completed
-
GlaxoSmithKlineCompletedSjogren's SyndromeSpain, France, Germany, Netherlands, United Kingdom, Sweden, Argentina, Italy, Canada, Norway
-
Rockefeller UniversityIcahn School of Medicine at Mount SinaiCompletedAtopic DermatitisUnited States
-
Shoichi Maruyama MD PhDRecruitingGlomerulonephritis, Membranous | Nephrotic Syndrome，IdiopathicJapan
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
Nagoya UniversityJapan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.CompletedChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Japan
-
Seoul National University Childrens HospitalUnknownSteroid Resistant Nephrotic Syndrome | Steroid Dependent Nephrotic SyndromeKorea, Republic of
-
National Institute of Neurological Disorders and...Completed
-
BiogenTerminated
-
CelgeneActive, not recruitingNeoplasmsUnited States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Hopital FochMinistry of Health, FranceRecruiting
-
Assistance Publique - Hôpitaux de ParisGlaxoSmithKlineRecruitingPrimary Immune Thrombocytopenia (ITP)France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Tokyo UniversityJapan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.CompletedAutoimmune Diseases | Collagen Diseases | Scleroderma, Systemic | Lung Fibrosis | Skin SclerosisJapan
-
University of Cape TownCompletedKerosene PneumonitisSouth Africa
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedType 1 Diabetes MellitusUnited States, Canada, Italy, Australia
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
PfizerCompletedRheumatoid ArthritisUnited States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
-
University Hospital, RouenRecruitingSevere Forms of Mucous Membrane PemphigoidFrance
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.TerminatedFollicular LymphomaItaly, Israel, Germany, France, Greece, Spain, Switzerland
-
Mabion SAParexelWithdrawn
-
Pakistan Institute of Medical SciencesWorld Health OrganizationCompletedPneumonia | Acute Respiratory InfectionsPakistan
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupActive, not recruitingEosinophilic Granulomatosis With PolyangiitisFrance
-
Pharmacyclics LLC.Active, not recruitingFollicular LymphomaUnited Kingdom, Portugal, Taiwan, Spain, Belgium, Netherlands, Israel, United States, Czechia, Italy, France, Hungary, Australia, Poland, Canada, Austria, Russian Federation, Greece, Turkey
-
University Hospital, BrestMinistry of Health, FranceCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedComparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)ANCA-associated VasculitidesFrance
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingChildren | Blood Disease | Rituximab
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation...Completed
-
Groupe Oncologie Radiotherapie Tete et CouRecruitingSquamous Cell Carcinoma of the Head and NeckFrance
-
Gruppo Italiano Studio LinfomiCompleted
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
Olatec Therapeutics LLCCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
University Hospital, ToulouseCompletedAutoimmune Diseases | Renal TransplantFrance
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
University of CopenhagenRigshospitalet, DenmarkCompletedFatigue | Keratoconjunctivitis Sicca | Primary Sjögren's Syndrome | Xerostomia | HyposalivationDenmark
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Hoffmann-La RocheTerminatedRheumatoid ArthritisFrance, Germany, Switzerland, United Kingdom, Spain, Netherlands, Greece, Poland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular LymphomaUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.TerminatedPrimary Central Nervous System LymphomaUnited States